Ryan Jason's most recent trade in Sinclair Inc - Ordinary Shares - Class A was a trade of 9,214 Class A Common Stock done at an average price of $15.6 . Disclosure was reported to the exchange on March 8, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Sinclair Inc (Class A) | Jason Ryan Smith | Executive Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 15.60 per share. | 08 Mar 2026 | 9,214 | 291,905 (0%) | 0% | 15.6 | 143,738 | Class A Common Stock |
| Sinclair Inc (Class A) | Jason Ryan Smith | Executive Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 16.34 per share. | 28 Feb 2026 | 34,099 | 301,119 (0%) | 0% | 16.3 | 557,178 | Class A Common Stock |
| Sinclair Inc (Class A) | Jason Ryan Smith | Executive Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Feb 2026 | 144,300 | 335,218 (0%) | 0% | - | Class A Common Stock | |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Feb 2026 | 69,271 | 244,837 (0%) | 0% | 0 | Common Stock | |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.64 per share. | 19 Feb 2026 | 23,868 | 220,969 (0%) | 0% | 42.6 | 1,017,732 | Common Stock |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.64 per share. | 19 Feb 2026 | 7,813 | 213,156 (0%) | 0% | 42.6 | 333,146 | Common Stock |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2026 | 13,666 | 175,566 (0%) | 0% | 0 | Common Stock | |
| Bankwell Fin Grp Inc | Ryan Jason Hildebrand | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2026 | 3,116 | 3,116 (0%) | 0% | 0 | Common Stock | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Sale of securities on an exchange or to another person at price $ 129.59 per share. | 27 Aug 2025 | 9,890 | 104,784 | - | 129.6 | 1,281,690 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Sale of securities on an exchange or to another person at price $ 126.15 per share. | 27 Aug 2025 | 8,969 | 123,569 | - | 126.2 | 1,131,472 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Sale of securities on an exchange or to another person at price $ 125.07 per share. | 27 Aug 2025 | 8,818 | 132,538 | - | 125.1 | 1,102,893 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Sale of securities on an exchange or to another person at price $ 127.44 per share. | 27 Aug 2025 | 5,443 | 118,126 | - | 127.4 | 693,641 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Sale of securities on an exchange or to another person at price $ 128.04 per share. | 27 Aug 2025 | 3,452 | 114,674 | - | 128.0 | 441,997 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Sale of securities on an exchange or to another person at price $ 130.01 per share. | 27 Aug 2025 | 1,500 | 103,284 | - | 130.0 | 195,015 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Sale of securities on an exchange or to another person at price $ 129.65 per share. | 27 Aug 2025 | 1,150 | 11,904 | - | 129.6 | 149,093 | Class A Common Stock |
| Bankwell Fin Grp Inc | Ryan Jason Hildebrand | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 39.69 per share. | 04 Aug 2025 | 2,051 | 0 (0%) | 0% | 39.7 | 81,404 | Common Stock |
| Bankwell Fin Grp Inc | Ryan Jason Hildebrand | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 36.86 per share. | 01 Jul 2025 | 1,282 | 2,051 (0%) | 0% | 36.9 | 47,255 | Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 12,924 | 13,054 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jun 2025 | 12,924 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 3,576 | 3,576 | - | - | Restricted Stock Unit | |
| Bankwell Fin Grp Inc | Ryan Jason Hildebrand | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 35.49 per share. | 11 Jun 2025 | 1,885 | 0 (0%) | 0% | 35.5 | 66,899 | Common Stock |
| Sinclair Inc (Class A) | Jason Ryan Smith | Executive Vice Chairman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.40 per share. | 08 Mar 2025 | 6,255 | 190,918 (0%) | 0% | 14.4 | 90,072 | Class A Common Stock |
| Sinclair Inc (Class A) | Jason Ryan Smith | Executive Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 159,607 | 197,173 (0%) | 0% | - | Class A Common Stock | |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2025 | 35,004 | 175,688 (0%) | 0% | 0 | Common Stock | |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.73 per share. | 20 Feb 2025 | 9,473 | 166,215 (0%) | 0% | 33.7 | 319,524 | Common Stock |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 33.73 per share. | 20 Feb 2025 | 4,315 | 161,900 (0%) | 0% | 33.7 | 145,545 | Common Stock |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 9,853 | 140,684 (0%) | 0% | 0 | Common Stock | |
| Bankwell Fin Grp Inc | Ryan Jason Hildebrand | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2025 | 15,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 19 Nov 2024 | 141,356 | 47,000 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Sale of securities on an exchange or to another person at price $ 71.35 per share. | 19 Nov 2024 | 24,784 | 16,264 | - | 71.4 | 1,768,420 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Sale of securities on an exchange or to another person at price $ 68.36 per share. | 19 Nov 2024 | 9,361 | 6,129 | - | 68.4 | 639,876 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Sale of securities on an exchange or to another person at price $ 70.86 per share. | 19 Nov 2024 | 5,952 | 41,048 | - | 70.9 | 421,784 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Sale of securities on an exchange or to another person at price $ 70.50 per share. | 19 Nov 2024 | 4,272 | 0 | - | 70.5 | 301,185 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Sale of securities on an exchange or to another person at price $ 69.84 per share. | 19 Nov 2024 | 1,857 | 4,272 | - | 69.8 | 129,689 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Sale of securities on an exchange or to another person at price $ 72.26 per share. | 19 Nov 2024 | 774 | 15,490 | - | 72.3 | 55,927 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 130 | 73,744 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2024 | 130 | 0 | - | - | Restricted Stock Unit | |
| Bankwell Fin Grp Inc | Ryan Jason Hildebrand | Chief Innovation Officer | Sale of securities on an exchange or to another person at price $ 25.02 per share. | 01 Jul 2024 | 1,448 | 1,885 (0%) | 0% | 25.0 | 36,229 | Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 12,924 | 12,924 | - | - | Restricted Stock Unit | |
| Singular Genomics Systems Inc | Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 74,000 | 74,000 | - | - | Stock Option (Right to Buy) | |
| CenterPoint Energy | Ryan Michael Jason | EVP, Reg. Svcs. & Gov. Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Feb 2024 | 50,532 | 149,166 (0%) | 0% | 0 | Common Stock | |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.79 per share. | 20 Feb 2024 | 14,652 | 134,514 (0%) | 0% | 27.8 | 407,179 | Common Stock |
| CenterPoint Energy | Michael Ryan Jason | EVP, Reg. Svcs. & Gov. Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.79 per share. | 20 Feb 2024 | 3,683 | 130,831 (0%) | 0% | 27.8 | 102,351 | Common Stock |
| CenterPoint Energy | Michael Jason Ryan | EVP, Reg. Svcs. & Gov. Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 9,419 | 98,634 (0%) | 0% | 0 | Common Stock | |
| GeneDx Holdings Corp (Class A) | Ryan Jason | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 11 Jan 2024 | 73,614 | 0 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 67,780 | 73,614 | - | 0 | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 46,000 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Ryan Jason | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2023 | 21,780 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 1.54 per share. | 16 Nov 2023 | 58,000 | 114,742 | - | 1.5 | 89,181 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director, Executive Chairman | Purchase of securities on an exchange or from another person at price $ 1.27 per share. | 16 Nov 2023 | 56,742 | 56,742 | - | 1.3 | 72,187 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 3.19 per share. | 17 Oct 2023 | 42 | 5,834 | - | 3.2 | 134 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2023 | 129 | 5,876 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2023 | 129 | 130 | - | - | Restricted Stock Unit | |
| Bankwell Fin Grp Inc | Ryan Jason Hildebrand | Chief Innovation Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Aug 2023 | 10,000 | 10,000 (0%) | 0% | 0 | Common Stock | |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jul 2023 | 4,671 | 89,215 (0%) | 0% | 0 | Common Stock | |
| SomaLogic Inc - Ordinary S... | Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 185,400 | 185,400 | - | - | Employee Stock Option (Right to Buy) | |
| SomaLogic Inc - Ordinary S... | Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 14,650 | 14,650 | - | - | Employee Stock Option (Right to Buy) | |
| SomaLogic Inc - Ordinary S... | Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 3,400 | 3,400 | - | - | Restricted Stock Unit (RSU) | |
| Singular Genomics Systems Inc | Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 74,000 | 74,000 | - | - | Stock Option (Right to Buy) | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Apr 2023 | 1,518,000 | 1,518,000 | - | - | Restricted Stock Unit | |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2023 | 43,224 | 100,206 (0%) | 0% | 0 | Common Stock | |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.21 per share. | 17 Feb 2023 | 12,017 | 88,189 (0%) | 0% | 29.2 | 351,017 | Common Stock |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.21 per share. | 17 Feb 2023 | 3,645 | 84,544 (0%) | 0% | 29.2 | 106,470 | Common Stock |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 8,754 | 56,982 (0%) | 0% | 0 | Common Stock | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 247,525 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 247,525 | 263,358 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 0.26 per share. | 31 Dec 2022 | 73,732 | 189,626 | - | 0.3 | 19,310 | Class A Common Stock |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Dec 2022 | 718,753 | 718,753 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 4,278 | 17,114 | - | - | Class A Common Stock | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director, Executive Chairman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Oct 2022 | 4,278 | 8,558 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director, Executive Chairman | Sale of securities on an exchange or to another person at price $ 0.86 per share. | 15 Oct 2022 | 1,281 | 15,833 | - | 0.9 | 1,101 | Class A Common Stock |
| Singular Genomics Systems Inc | Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 46,250 | 46,250 | - | - | Stock Option (Right to Buy) | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 12,836 | 0 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Apr 2022 | 12,836 | 12,836 | - | - | Class A Common Stock | |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Feb 2022 | 7,114 | 49,948 (0%) | 0% | 0 | Common Stock | |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.20 per share. | 22 Feb 2022 | 1,720 | 48,228 (0%) | 0% | 27.2 | 46,784 | Common Stock |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.61 per share. | 18 Feb 2022 | 1,108 | 42,834 (0%) | 0% | 26.6 | 29,484 | Common Stock |
| CenterPoint Energy | Jason Michael Ryan | EVP, Reg. Svcs. & Gov. Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 7,824 | 43,942 (0%) | 0% | 0 | Common Stock | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 429,730 | 429,730 | - | - | Stock Option (right to buy) | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 247,525 | 247,525 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 22,286 | 22,286 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 22,286 | 22,286 | - | - | Employee Stock Option (Right to Buy) | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 12,836 | 12,836 | - | - | Restricted Stock Unit | |
| GeneDx Holdings Corp (Class A) | Jason Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Oct 2021 | 12,836 | 12,836 | - | - | Restricted Stock Unit |